The Effect of Switch Treatment on Liver Fibrosis and qHBsAg Levels in Patients with Chronic Hepatitis B


Yesilyurt E., Kaya M., Dindar G., Acikgoz S. B. , Guzelbulut F., Sezikli H., ...More

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.26, pp.69-73, 2020 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 26
  • Publication Date: 2020
  • Doi Number: 10.4274/vhd.galenos.2020.2020.0008
  • Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Page Numbers: pp.69-73

Abstract

Objectives: The aim of this study was to evaluate the relationship between clinical, biochemical, serological parameters, fibroscan imaging in terms of fibrosis and quantitative hepatitis B surface antigen (qHBsAg) levels in patients with chronic hepatitis B (CHB) infection whose treatment has been switched from LAM to TDF.